Researchers found that patients with obesity had an average weight loss of 12.9% with semaglutide vs 5.6% with liraglutide ...

Semaglutide injections effectively support weight loss by regulating appetite and glucose levels, offering benefits for ...

Introduction ADVERTISEMENT Peptides have become a focal point in research due to their intricate interactions with metabolic ...

Novo Nordisk, a leader in the worldwide diabetes and obesity care market, has been witnessing stellar performance of its ...

Due to increased demand, price hikes and long-term shortages, obtaining prescriptions for weight loss drugs such as ...

For weight loss, weight management, and overall wellness, focus on eating healthy foods, like high-protein meals, legumes, ...

Novo Nordisk's Wegovy label update receives a positive opinion from the EMA's CHMP, highlighting improvements in heart ...

Novo Nordisk receives a positive opinion from the CHMP for a label update of Wegovy to reflect reduced heart failure symptoms ...

Whether positive or negative, your mood may feel different on GLP-1 medications. Researchers share why that might be and how ...

Novo Nordisk has announced positive Phase IIa results for monlunabant, a small molecule oral CB1 inverse agonist for obesity.

What is Ozempic? An injectable drug that can be prescribed by your GP to manage Type 2 diabetes. It has also been labelled a ...

Three scientists were recognized by the Lasker Awards for their work on the GLP-1 hormone. Others were honored for work to ...